This study evaluated the reproducibility of nerve function assessment
in a group of 132 diabetic patients with moderate peripheral polyneuro
pathy. Patients were investigated at the beginning and the end of the
run-in period (a 1-month placebo period) of a multicentre trial of an
aldose-reductase inhibitor (Ponalrestat). Reproducibility was evaluate
d by performing four types of tests: quantitative visual scales of sym
ptoms, quantitative sensory assessment (vibration perception threshold
s in medial malleolus and great toe, foot thermal perception threshold
to hot and cold), electrophysiological investigations on the dominant
side (conduction velocities and potential amplitudes of sensory and m
edian motor nerve, sural and peroneal nerves, amplitudes of F waves of
median motor and peroneal nerves) and cardiac autonomic tests (Valsal
va, deep-breathing, lying-to-standing), Reproducibility was poor for s
ymptoms, thermal sensitivity, and potential amplitudes. It was satisfa
ctory (total coefficient of variation < 50 %) for all the other parame
ters and even very good (total variation coefficient < 26 %, intra-sub
ject variation factors corresponding to < 56 % of total variance) for
velocities of sensory and median motor and peroneal nerves, the amplit
udes of F waves and the three autonomic tests. For most of the paramet
ers total variance was mainly related to inter-subject variability. Ho
wever, inter-subject variability for the three cardiac autonomic tests
was very low and at least one cardiac autonomic test was altered in a
ll the patients. Inter-centre variability was low for all the paramete
rs, except for action potential amplitudes and for F wave velocity of
the median motor nerve. This study suggests those parameters that are
appropriate for the assessment of diabetic neuropathy and for therapeu
tic trials. It also shows evidence of cardiac autonomic neuropathy in
all these patients with moderate peripheral neuropathy.